A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 421-429

  Koch, Ute ^a,b   Choksi, Swati ^a   Marcucci, Lisa ^a   Korngold, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN DERIVATIVE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SKIN ALLOGRAFT; SURVIVAL TIME; THYMECTOMY; TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION, SECONDARY; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, NUDE; OLIGOPEPTIDES; SKIN TRANSPLANTATION; STEM CELLS; THYMECTOMY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031830636     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Hall, B. M. 1991. Cells mediating allograft rejection. J. Exp. Med. 169:779.
2. Wood, K. J., T. C. Pearson, C. Darby, and P. J. Morris. 1991. CD4: a potential target molecule for immunosuppressive therapy and tolerance induction. Transplantation 5:150.
3. Darby, C. R., A. Bushell, P. J. Morris, and K. J. Wood. 1994. Nondepleting anti-CD4 antibodies in transplantation: evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 57:1419.
4. Qin, S. X., M. Wise, S. P. Cobbold, L. Leong, Y. C. Kong, J. R. Parnes, and H. Waldmann. 1990. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20:2737.
5. Saitovitch, D., A. R. Bushell, P. J. Morris, and K. J. Wood. 1995. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. Transplant. Proc. 27:117.
6. Jameson, B. A., J. M. McDonnell, J. C. Marini, and R. Korngold. 1994. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744.
7. + T cell responses in experimental allergic encephalomyelitis. J. Immunol. 157:3706.
8. Townsend, R. M., C. Briggs, J. C. Marini, G. F. Murphy, and R. Korngold. 1996. Inhibitory effect of a CD4-CDR3 peptide analog on graft-versus-host disease across a major histocompatibility complex-haploidentical barrier. Blood 88:3038.
9. Koch, U., and R. Korngold. 1997. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers. Blood 89:2880.
10. Bruce, J., F. W. Symington, T. J. McKearn, and J. Sprent. 1981. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127:2496.
11. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
12. Fujihashi, K., J. R. McGhee, K. W. Beagley, D. T. McPherson, S. A. McPherson, C. M. Huang, and H. Kiyono. 1993. Cytokine-specific ELISPOT assay: single cell analysis of IL-2, IL-4 and IL-6 producing cells. J. Immunol. Methods 160: 181.
13. Taguchi, T., J. R. McGhee, R. L. Coffman, K. W. Beagley, J. H. Eldridge, K. Takatsu, and H. Kiyono. 1990. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J. Immunol. Methods 128:65.
14. Klinman, D., and T. Nutman. 1994. ELISPOT assay to detect cytokine-secreting murine and human cells. In Current Protocols in Immunology, 2nd Ed. J. E. Coligan, ed. John Wiley & Sons, Inc., New York, p. 191.
15. Bailey, D. W., and B. Usama. 1960. A rapid method of grafting skin on tails of mice. Transplant. Bull. 7:424.
16. Gieni, R. S., X. Yang, A. Kelso, and K. T. Hayglass. 1996. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Immunology 87:119.
17. Czerkinsky, C., G. Andersson, H. P. Ekre, L. A. Nilsson, L. Klareskog, and O. Ouchterlony. 1988. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110:29.
18. Weyand, C. M., J. Goronzy, K. Swarztrauber, and C. G. Fathman. 1989. Immunosuppression by anti-CD4 treatment in vivo: cellular and humoral responses to alloantigens. Transplantation 47:1039.
19. Chace, J. H., J. S. Cowdery, and E. H. Field: 1994. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J. Immunol. 152:405.
20. Fangmann, J., R. Dalchau, and J. W. Fahre. 1992. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175:1521.
21. Essery, G., M. Feldmann, and J. R. Lamb. 1988. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 64:413.
22. Beverly, B., S. M. Kang, M. J. Lenardo, and R. H. Schwartz. 1992. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:661.
23. Cobbold, S. P., E. Adams, S. E. Marshall, J. D. Davies, and H. Waldmann. 1996. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CDS. Immunol. Rev. 149:5.
24. + Th1 but not Th2 cytokine responses. Int. Immunol. 6:721.
25. Wood, K. J. 1990. Transplantation tolerance with monoclonal antibodies. Semin. Immunol. 2:389.
26. Waldmann, T. A. 1992. Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection. Annu. Rev. Immunol. 10:675.
27. Hafler, D. A., J. Ritz, S. F. Schlossman, and H. L. Weiner. 1988. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis: immunosuppressive effects and human anti-mouse responses. J. Immunol. 141:131.
28. Horneff, G., T. Winkler, J. R. Kalden, F. Emmrich, and G. R. Burmester. 1991. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis. Clin. Immunol. Immunopathol. 59: 89.
29. Winter, G., and W. J. Harris. 1993. Humanized antibodies. Immunol. Today 14: 243.
30. Roguska, M. A., J. T. Pedersen, C. A. Keddy, A. H. Henry, S. J. Searle, J. M. Lambert, V. S. Goldmacher, W. A. Blattler, A. R. Rees, and B. C. Guild. 1994. Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc. Natl. Acad. Sci. USA 91:969.
31. Goronzy, J., C. M. Weyand, and C. G. Fathman. 1986. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4. J. Exp. Med. 164:911.
32. Racadot, E., L. Rumbach, M. Bataillard, J. Galmiche, J-L. Henlin, M. Truttmann, P. Herve, and J. Wijdenes. 1993. Treatment of multiple sclerosis with anti-CD4 monoclonal antibody: a preliminary report on B-F5 in 21 patients. J. Autoimmun. 6:771.
33. Morrison, W. J., N. J. Kennedy, H. Offner, and A. A. Vandenbark. 1995. Effects of anti-CD4 antibody: enhancement of lymph node PPD-memory T cell response. Cell. Immunol. 163:106.
34. Schlitt, H. J., R. Schwinzer, R. Kurrle, and K. Wonigeit. 1988. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex. Transplant Proc. 20:103.
35. Russell, P. S., R. B. Colvin, and A. B. Cosimi. 1984. Monoclonal antibodies for the diagnosis and treatment of transplant rejection. Annu. Rev. Med. 35:63.
36. Steinman, L., J. T. Rosenbaum, S. Sriram, and H. O. McDevitt. 1981. In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc. Natl. Acad. Sci. USA 78:7111.
37. Priestley, C. A., S. C. Spencer, G. J. Sawyer, and J. W. Fabre. 1992. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific anti-bodies to class II MHC antigens. Transplantation 53:1024.
38. Cavazzana-Calvo, M., S. Sarnacki, E. Haddad, C. De Coene, D. Calise, E. Yvon, N. Cerf-Bensussan, and A. Fischer. 1995. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody. Transplantation 59:1576.
39. Van Gool, S. W., J. L. Ceuppens, H. Walter, and M. de Boer. 1994. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood 83:176.
40. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Q. Wei, M. L. Gibson, X. G. Zheng, S. Myrdal, and D. Gordon. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89:11102.
41. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257:789.
42. Isobe, M., H. Yagita, K. Okumura, and A. Ihara. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125.
43. Paul, L. C., A. Davidoff, H. Benediktsson, and T. B. Issekutz. 1993. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation 55:1196.
44. McDonnell, J. M., K. J. Blank, P. E. Rao, and B. A. Jameson. 1992. Direct involvement of the CDR3-like domain of CD4 in T helper cell activation. J. Immunol. 149:1626.
45. Huang, Z., S. Li, and R. Korngold. 1997. Immunoglobulin superfamily proteins: structure, function, and drug discovery. Biopoly 43:367.
46. Langedijk, J. P. M., W. C. Puijk, W. P. Van Hoorn, and R. H. Meloen. 1993. Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC. J. Biol. Chem. 268:16875.
47. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
48. Konig, R., X. Shen, and R. N. Germain. 1995. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779.
49. Sakihama, T., A. Smolyar, and E. L Reinherz. 1995. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA 92:6444.
50. lck. Nature 338:257.
51. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511.
52. Newell, M. K., L. J. Haughn, C. Maroun, and M. H. Julius. 1990. Death of mature T cells by separate ligation of CD4 and T-cell receptor for antigen. Nature 347: 286.
53. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
54. Mondino, A., and M. K. Jenkins. 1994. Surface proteins involved in T cell costimulation. J. Leukocyte Biol. 55:805.
55. + T cell subsets. Clin. Exp. Allergy 25:839.
56. Hu, Q., D. Davidson, P. L. Schwartzberg, F. Macchiarini, M. J. Lenardo, J. A. Bluestone, and L. A. Matis. 1995. Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J. Biol Chem. 270:1928.
57. Perez, V. L., L. van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
58. Fowler, D. H., K. Kurasawa, R. Smith, and R. E. Gress. 1994. Donor lymphoid cells of Th2 cytokine phenotype reduce lethal graft versus host disease and facilitate fully allogeneic cell transfers in sublethally irradiated mice. Prog. Clin. Biol. Res. 389:533.
59. + donor T cells fail to induce experimental acute graft-versus-host disease. J. Immunol. 155:585.
60. Khoury, S. J., E. Akalin, A. Chandraker, L. A. Turka, P. S. Linsley, M. H. Sayegh, and W. W. Hancock. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155:4521.
61. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185.
62. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn, and T. C. Pearson. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.